Another InnovativeTest Designed by WANTAI QUANTITATIVE ELISA for IgG Antibody to COVID-19 For monitoring antibody level after vaccination Leading infectious diseases diagnostic test manufacturer Your Global Partner in IVD WANTAI SARS-CoV-2 IgG ELISA is an ELISA intended for quantitative detection of IgG-class antibodies to SARS-CoV-2 virus in human serum or plasma. It works as an aid in detecting immune response levels for individuals infected with SARS-CoV-2, or in individuals who have received COVID-19 vaccination. E-mail: [email protected] Website: www.ystwt.cn

Intended Use The WANTAI SARS-CoV-2 IgG ELISA (Quantitative) is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection, or as an aid in individual vaccination management decisions. The quantitative result obtained with this kit is as a reference for clinician only, cannot be used as the sole basis for further individual vaccination and treatment. In June 2020, NIBSC filled and freeze-dried the candidate International Standard, NIBSC code 20/136 and the Reference Panel members (NIBSC codes 20/140, 20/142, 20/144,...

Microwell strips pre-coated with - recombinant, highly immunoreactive SARS-CoV-2 antigens S-RBD antigen HRP-conjugated anti-human IgG Add 10μl of Specimens/ Controls Incubation at 37℃ for 30 min Add 50μl of Chromogen Solution A and 50μl of Chromogen Solution B Incubation at 37℃ for 15 min Read by single wavelength 450nm or dual wavelength 450/600~650nm Pack size